Neutrophil-to-lymphocyte ratio as a prognostic factor in patients with castration-resistant prostate cancer treated with docetaxel-based chemotherapy: a meta-analysis
Abstract Background In recent years, many studies have illustrated that the neutrophil-to-lymphocyte ratio (NLR) is a prognostic factor of metastatic castration-resistant prostate cancer (mCRPC), but their conclusions are controversial. The aim of this study was to assess the prognostic value of the...
Saved in:
| Main Authors: | Ying Zhang, Xiao Zhou, Ran Xu, Guangcheng Luo, Xinjun Wang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-01-01
|
| Series: | BMC Urology |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12894-024-01685-4 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Neutrophil and neutrophil-lymphocyte ratios as predictors of clinical characteristics in patients with Lymphangioleiomyomatosis
by: Lulu Yang, et al.
Published: (2025-06-01) -
PSA LEVEL AND ADVERSE EVENTS IN SIXTH AND TENTH SERIES DOCETAXEL CHEMOTHERAPY IN CASTRATE-RESISTANT PROSTATE CANCER (CRPC) PATIENTS
by: Kurnia Penta Seputra, et al.
Published: (2025-01-01) -
Neutrophil-to-lymphocyte ratio dynamics: prognostic value and potential for surveilling glioblastoma recurrence
by: Meng-Wu Chung, et al.
Published: (2025-04-01) -
Prognostic value of peripheral blood neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients with gastric cancer
by: ZHANG Le, LI Wei, HUANG Zeping, WANG Wenjie, CHEN Xiao
Published: (2025-01-01) -
Role of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as prognostic markers in oral cavity cancers
by: Akshat Malik, et al.
Published: (2019-01-01)